Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
Institution:
1. Department of Hematology and Oncology, School of Medicine, University of Alabama, Birmingham, AL 35201, USA;2. Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Abstract:
Antitumor agents are delivered via nanoparticles (NPs) to the mitochondria. The drugs attack the mitochondria resulting in mitochondrial damage and the release of cytochrome C (Cyto-C). Cyto-C binds with Apaf1 and Caspase-9 to form an apoptosome. The apoptosome activates Caspase 3, which ultimately results in the death of cancer cells.